Therapeutic TREM-1 peptides

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10603357
APP PUB NO 20160193288A1
SERIAL NO

14968479

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRISTOL-MYERS SQUIBB COMPANY345 PARK AVENUE NEW YORK N Y 10154

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Faure, Gilbert Vandoeuvre les Nancy, FR 7 79
Gibot, Sebastien Vandoeuvre les Nancy, FR 10 84
Panina, Paola Milan, IT 12 102
Passini, Nadia Milan, IT 6 62

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 30, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 30, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00